IP Library Granted Patent US 8,097,695
Granted Patent B2
US 8,097,695 · App. 12/547,369 · Granted Jan 17, 2012

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,097,695
App. No.
12/547,369
Granted
Jan 17, 2012
Kind
B2
Abstract

The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided.

Claims (20)

1. A compound having the formula:

wherein POLY is a water-soluble polymer, (n) is 3 to about 25, X is a linking group, Y is a moiety derived from a molecule having at least three nucleophilic groups, and R is an organic radical.

2. The compound of claim 1 , wherein the water-soluble polymer is a poly(ethylene glycol).

3. The compound of claim 1 , wherein (n) is 3 to 10.

4. The compound of claim 3 , wherein (n) is 3.

5. The compound of claim 3 , wherein (n) is 4.

6. The compound of claim 3 , wherein (n) is 5.

7. The compound of claim 6 , wherein (n) is 6.

8. The compound of claim 1 , wherein the organic radical is alkyl or aryl.

9. The compound of claim 1 , wherein the organic radical is methyl.

10. The compound of claim 1 , wherein the organic radical is phenyl.

11. The compound of claim 2 , wherein the poly(ethylene glycol) has a molecular weight of from 200 Da to about 20,000 Daltons.

12. The compound of claim 11 , wherein the poly(ethylene glycol) has a molecular weight of from 500 Da to about 15,000 Daltons.

13. The compound of claim 11 , wherein the poly(ethylene glycol) has a molecular weight of from 600 Da to about 6,000 Daltons.

14. The compound of claim 1 , wherein the molecule having at least three nucleophilic groups is selected from the group consisting of glycerol, oligoglycerols, pentaerythritol, carbohydrates, and cyclodextrin.

15. The compound of claim 1 , wherein the molecule having at least three nucleophilic groups is glycerol.

16. The compound of claim 1 , wherein the molecule having at least three nucleophilic groups is an oligoglycerol.

17. The compound of claim 1 , wherein the molecule having at least three nucleophilic groups is

18. The compound of claim 1 , wherein the molecule having at least three nucleophilic groups is pentaerythritol.

19. The compound of claim 1 , wherein the molecule having at least three nucleophilic groups is 1,2,3-propane-triamine.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Oct 16, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023386/0282 →